超越血压:盐敏感性作为心脏表现型-一个叙事评论
Maria Bachlitzanaki1, Georgios Aletras2,3, Eirini Bachlitzanaki2
1Department of Internal Medicine, Venizelio General Hospital of Heraklion, 71409 Heraklion, Greece.
Life (Basel, Switzerland)
|February 27, 2026
概括
盐敏感血压 (SSBP) 涉及异常的处理,影响脏和心脏. 早期识别和量身定制的治疗,包括药物和生活方式的改变,可以改善这种高血压表型的心脏和脏结果.
科学领域:
- 心血管医学 心血管医学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 高血压研究 高血压研究
背景情况:
- 盐敏感血压 (SSBP) 是一种未被认可的高血压表型,其中血压和体积状况受到饮食中的的严重影响.
- 它涉及处理,神经激素激活,血管功能障碍和炎症的复杂相互作用,导致损伤和心脏重塑.
- SSBP与慢性病 (CKD) 和心力衰竭与保留喷射分数 (HFpEF) 相关,突出其临床意义.
研究的目的:
- 审查SSBP目前的机械和临床证据.
- 专注于病理生理学,心交互,诊断挑战和实际的,以表型为指导的治疗策略.
主要方法:
- 使用主要科学数据库 (PubMed,Scopus,Web of Science) 进行了叙事文献审查.
- 综合实验,翻译和临床研究,以及指导文档,以进行全面的解释.
主要成果:
- 关键机制包括脏分泌受损,内RAAS激活,交感过活,内皮功能障碍和炎症,影响心轴.
- 临床表现包括不下降的血压,白蛋白尿,,以及对HFpEF的倾向.
- 动态BP监测和有针对性的实验室评估有助于确定SSBP和指导管理.
结论:
- 早期识别SSBP允许干预超出一般的限制.
- 以表型为指导的疗法,包括改变生活方式和特定药物类别 (RAAS阻塞,利尿剂,MRA,SGLT2i),可能会增强心脏结局.
- 对于BP和监测的新兴技术显示了个性化管理的前景.
相关概念视频
Hypertension and Regulation of Blood Pressure
4.6K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.6K
Hypertension II: Pathophysiology
1.2K
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.2K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.3K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.3K
Heart Failure II: Pathophysiology
1.1K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.1K
Antihypertensive Drugs: Potassium-Sparing Diuretics
2.5K
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
2.5K
Heart Failure Drugs: Diuretics
1.1K
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.1K


